Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis

NCT00078338 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

764

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing-remitting Multiple Sclerosis

Interventions

DRUG: Rebif®
DRUG: Copaxone®

Sponsor

EMD Serono

Collaborators

[object Object]